I want a decent dividend stock in pharma to add to my portfolio and after looking around Pfizer looks like a good choice.
The only problem being that Lyrica patent doesn't end till June which the stock should drop a little at from.
Is it better to wait for this drop or buy in now as its unlikely that the Lyrica change will affect it enough that it will matter to wait.
TLDR; any Pharma stock bros know how bad that patent expirings on strong seller drugs affect the companies stock price?
Submitted March 25, 2019 at 08:23AM by CookhouseOfCanada https://ift.tt/2FyNmnB
